Latest China News

Sigma Healthcare reports robust growth in Chemist Warehouse sales across Australia and internationally, announces a joint venture to enter the UK market, and secures a major distribution centre lease in New Zealand to support its expanding network.

Murray Cod Australia (ASX:MCA) is raising $18.6 million through a fully underwritten entitlement offer at a steep 43% discount to last price, aiming to convert its record 3,700-tonne biomass into sales and expand processing capacity.

Merino & Co. has secured a three-year exclusive distribution agreement in Mainland China, guaranteeing a minimum annual order of CNY 30 million (~AUD 6.5 million) and targeting 20% yearly growth upon renewal.

AdAlta has secured A$2.5 million in a strategic placement to push its lead CAR-T therapy BZDS1901 through critical US FDA regulatory steps and establish Australian manufacturing, building on promising clinical responses in advanced mesothelioma.

Vanadium Resources raises about A$1 million through a placement to fund studies and site agreements for its Steelpoortdrift Vanadium Project and next-gen V-Iron Plant, aiming to supply Western critical mineral markets.

Merino & Co. reported Q3 FY26 revenue of A$441,558 with new domestic and China purchase orders supporting its growth strategy, while cash reserves fell to A$654,282 due to investments in production and marketing.

Tennant Minerals has delivered a standout diamond drilling result at its Bluebird copper-gold-bismuth discovery, extending high-grade mineralisation and highlighting bismuth’s rising strategic value.

Critical Resources has confirmed significant greisen-hosted tungsten mineralisation at Granite Creek, boosting its exploration priority in a market where tungsten prices have surged over eightfold since early 2025. Assay results from ongoing New Zealand field programs are due mid-2026.

Hastings Technology Metals secures 49% of a Thai hydromet plant, aiming for Q4 2026 production using African monazite feedstock, setting a path for early cash flow ahead of Yangibana.

Vanadium Resources (ASX: VR8) has taken major steps to commercialise its Steelpoortdrift project with a non-binding offtake deal with U.S. Vanadium and appointed Rand Merchant Bank to lead funding efforts.

Recce Pharmaceuticals bolsters its clinical and commercial pipeline with a $5.3 million AUD R&D tax rebate, a second U.S. Army research agreement for its RECCE 327 Gel, and a key patent granted in Brazil, while progressing Phase 3 trials in Indonesia.

Evion Group has secured key approvals from Madagascar’s Ministry of Mines to convert exploration permits into mining permits for its Maniry Graphite Project, backed by significant EU funding and US trade initiatives. Meanwhile, its Indian joint venture progresses a major graphite plant expansion to meet growing demand.